Jianhua Zhan

Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR Mutation

Nan Chen, Wenfeng Fang, Jianhua Zhan et al. · Journal of Thoracic Oncology · 2015 · 686 citations · Full text

Medicine, Immunology, Oncology +17

EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy

Wenfeng Fang, Jianwei Zhang, Shaodong Hong et al. · Oncotarget · 2014 · 390 citations · Full text

Life Sciences, Cancer Biology, Oncology +16

KRAS mutation-induced upregulation of PD-L1 mediates immune escape in human lung adenocarcinoma

Nan Chen, Wenfeng Fang, Lin Zhong et al. · Cancer Immunology Immunotherapy · 2017 · 294 citations · Full text

Medicine, Immunology, Oncology +17

The association between PD-L1 and EGFR status and the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs

Yanna Tang, Wenfeng Fang, Yaxiong Zhang et al. · Oncotarget · 2015 · 243 citations · Full text

Medicine, Oncology, Molecular Oncology +14

Expression of programmed death ligand-1 on tumor cells varies pre and post chemotherapy in non-small cell lung cancer

Sheng Jin, Wenfeng Fang, Juan Yu et al. · Scientific Reports · 2016 · 201 citations · Full text

Life Sciences, Immunology, Oncology +14